Hear from Dr. Michel Sadelain and Dr. Jae Park about the potential of CAR T-cell therapy in the treatment of cancer. They discuss its origins, clinical success in blood cancers, potential side effects, and strategies to enhance accessibility. Both doctors express optimism for CAR T-cell therapy's future in treating a wider range of cancers, including solid tumors.